TRUE OR FALSE: According to the 2017 HIV Medical Association (HIVMA) of Infectious Diseases Society of America’s (IDSA) Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV, opioid analgesics should be given as a first-line therapy for long-term management of chronic neuropathic pain in patients with HIV.
Better luck next time
The guidelines also include the following weak recommendation: “Clinicians may consider a time-limited trial of opioid analgesics for patients who do not respond to first-line therapies and who report moderate to severe pain. As a second- or third-line treatment for chronic neuropathic pain, a typical adult regimen should start with the smallest effective dose and combine short- and long-acting opioids.”
For more HIV content, visit the Resource Center.